Evaluation of susceptibility testing methods for aztreonam (ATM) and ceftazidime/avibactam (CZA) combination therapy on extensively drug-resistant Gram-negative organisms,Antimicrobial Agents and Chemotherapy

当前位置： X-MOL 学术 › Antimicrob. Agents Chemother. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Evaluation of susceptibility testing methods for aztreonam (ATM) and ceftazidime/avibactam (CZA) combination therapy on extensively drug-resistant Gram-negative organisms
Antimicrobial Agents and Chemotherapy ( IF 4.9 ) Pub Date : 2021-08-23 , DOI: 10.1128/aac.00846-21
Ayesha Khan ₁ , Samuel G Erickson ₁ , Cedric Pettaway ₁ , Cesar A Arias _{1,

2} , William R Miller ₁ , Micah M Bhatti ₃

Affiliation

Carbapenem-resistant Enterobacterales (CRE) and Pseudomonas aeruginosa (CR-PA) producing Metallo-β-lactamases (MBLs) cause severe nosocomial infections with no defined treatment. The combination of Aztreonam (ATM) with ceftazidme-avibactam (CZA) is a ...

中文翻译：

氨曲南（ATM）和头孢他啶/阿维巴坦（CZA）联合治疗广泛耐药革兰氏阴性菌的药敏试验方法评价

产生金属-β-内酰胺酶 (MBL) 的耐碳青霉烯类肠杆菌 (CRE) 和铜绿假单胞菌 (CR-PA) 会导致严重的医院感染，但没有明确的治疗方法。氨曲南 (ATM) 与头孢他啶-阿维巴坦 (CZA) 的组合是...

更新日期：2021-09-12

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>